EIR Ventures
Europe, Stockholms Lan, Sweden, Stockholm
Description
EIR Ventures is a new Life Science Venture Group in the Nordics.
Investor Profile
EIR Ventures has backed more than 12 startups, with 0 new investments in the last 12 months alone. The firm has led 7 rounds, about 58% of its total and boasts 3 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series Unknown, Seed rounds (top funding stages).
- Majority of deals are located in Denmark, Sweden, United States.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
Stage Focus
- Series A (42%)
- Series Unknown (25%)
- Seed (17%)
- Series D (8%)
- Series B (8%)
Country Focus
- Denmark (50%)
- Sweden (33%)
- United States (8%)
- The Netherlands (8%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Health Diagnostics
- Biometrics
- Collaborative Consumption
- Life Science
- Biopharma
- Test And Measurement
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
